Nvidia CEO Jensen Huang will join over a dozen U.S. CEOs on President Donald Trump's visit to China this week, two sources familiar with the matter told Reuters on Wednesday. Huang did not appear on an initial list of executives provided by the White House earlier this week. Nvidia's powerful H200 chips have not yet been sold to China, a U.S. official said last month, citing difficulties ...
Nvidia CEO Jensen Huang will join over a dozen U.S. CEOs on President Donald Trump's visit to China this week, two sources familiar with the matter told Reuters on Wednesday. Huang did not appear on an initial list of executives provided by the White House earlier this week. Nvidia's powerful H200 chips have not yet been sold to China, a U.S. official said last month, citing difficulties getting permission from the Chinese government.
Nvidia CEO Jensen Huang has joined over a dozen U.S. CEOs on President Donald Trump's visit to China this week. Trump called Huang last-minute on Tuesday after seeing media coverage that he was not invited, according to one source familiar with the matter. Huang was seen by White House reporters boarding Air Force One in Alaska, joining Trump on his flight to China.
Nvidia CEO Jensen Huang has joined over a dozen U.S. CEOs on President Donald Trump's visit to China this week. Trump called Huang last-minute on Tuesday after seeing media coverage that he was not invited, according to one source familiar with the matter. Huang was seen by White House reporters boarding Air Force One in Alaska, joining Trump on his flight to China.
(RTTNews) - The Indonesia stock market has moved lower in three straight sessions, sinking almost 325 points or 4.3 percent in that span. The Jakarta Composite Index now rests just beneath the 6,860-point plateau and it may take further damage again on Wednesday.
(RTTNews) - The Indonesia stock market has moved lower in three straight sessions, sinking almost 325 points or 4.3 percent in that span. The Jakarta Composite Index now rests just beneath the 6,860-point plateau and it may take further damage again on Wednesday.
Earnings Call Insights: Relmada Therapeutics (RLMD) Q1 2026 Management View "Relmada continues to make excellent progress this year, and we are excited about where we stand," said CEO & Director Sergio Traversa, pointing to "the robust 12-months data for NDV-01" and "the successful completion of a $160 million private placement financing" while adding, "we remain on track to initiate the Phase 3 R...
Earnings Call Insights: Relmada Therapeutics (RLMD) Q1 2026 Management View "Relmada continues to make excellent progress this year, and we are excited about where we stand," said CEO & Director Sergio Traversa, pointing to "the robust 12-months data for NDV-01" and "the successful completion of a $160 million private placement financing" while adding, "we remain on track to initiate the Phase 3 RESCUE program in mid-2026." CEO Traversa described NDV-01 as "a ready-to-use sustained-release intravesical formulation of gemcitabine and docetaxel" designed to "deliver a best-in-class therapy" and said the company "achieved FDA alignment for our planned registrational Phase 3 RESCUE programs" and "fortified our balance sheet" so it "have the resources to support completion of the Phase 3 RESCUE program." On intellectual property, CEO Traversa said, "in April, we filed a provisional patent application in the U.S. directed to formulations and methods of treatment for NDV-01" and added, "If granted, it could form the basis for worldwide patent filings" and "extend the covered claims of NDV-01 into 2047." Chief Medical Officer of Urology Raj Pruthi highlighted Phase 2 results: "The data demonstrated a 95% complete response rate at any time" and "a durable 76% CR at 12 months" in high-risk NMIBC, plus "a 94% CR at any time" and "a durable 80% CR rate at 12 months" in BCG-unresponsive patients; he also said, "No patients had progression to muscle invasive disease and no patients underwent a radical cystectomy." CFO Maged Shenouda said, "Relmada closed the first quarter of 2026 with a cash balance of $234 million compared to $94 million at December 31, 2025," and added, "We expect our current cash resources to provide sufficient runway to fund company operations through 2029, including completion of the Phase 3 RESCUE program for NDV-01." Outlook CEO Traversa said, "we remain on track to initiate the registrational Phase 3 RESCUE program for NDV-01 in mid-2026" and added, "We a...
Earnings Call Insights: Fold Holdings (FLD) Q1 2026 Management View "Q1 was a challenging quarter across the broader Bitcoin industry. Lower Bitcoin prices pressured transaction volumes, trading activity, and consumer engagement, and Fold saw that pressure in our results." (Founder, CEO & Chairman of the Board William Reeves) "As of today, the Fold Credit Card is live with more than 1,000 cardhold...
Earnings Call Insights: Fold Holdings (FLD) Q1 2026 Management View "Q1 was a challenging quarter across the broader Bitcoin industry. Lower Bitcoin prices pressured transaction volumes, trading activity, and consumer engagement, and Fold saw that pressure in our results." (Founder, CEO & Chairman of the Board William Reeves) "As of today, the Fold Credit Card is live with more than 1,000 cardholders" and the company said it is "intentionally throttling access through a phased rollout" while it works through "our existing wait list of more than 8,000 potential users." (Founder, CEO & Chairman of the Board Reeves) "To support that growth, we are restructuring our gift card economics with distribution partners to materially reduce customer friction and improve retail placement opportunities" and management added that investors should "increasingly think about the gift card business as cost neutral on the front end." (Founder, CEO & Chairman of the Board Reeves) "Another important milestone this quarter was the launch of Fold's Bitcoin bonus program with Steak 'n Shake and others" and management said it is "already seeing meaningful interest from additional businesses exploring similar programs." (Founder, CEO & Chairman of the Board Reeves) "We saw that impact both our transactional volumes, which were down 31% year-over-year for the same period, and in our revenues, which were down 21% year-over-year for the same period." (Chief Financial Officer Wolfe Repass) Outlook "We remain on target with the rollout expectations and plan to continue expanding access through the quarters ahead" and the company said it is "working diligently on securing additional capital facilities to support larger scale growth of the credit card program." (Founder, CEO & Chairman of the Board William Reeves) "Given the timing of the launch, the credit card did not materially contribute to Q1 results" but management said, "as access expands, we expect the card to become an increasingly importan...
Artificial intelligence has shortened drug development from years to just 18 months, the founder of METiS TechBio said, as the AI-driven drug design start-up made its Hong Kong debut on Wednesday amid strong investor appetite for AI-related stocks in the city. “We see ourselves like a SpaceX-style company,” Lai Tsai-Ta, co-founder and CEO of METiS TechBio, who obtained a PhD from the Massachusetts...
Artificial intelligence has shortened drug development from years to just 18 months, the founder of METiS TechBio said, as the AI-driven drug design start-up made its Hong Kong debut on Wednesday amid strong investor appetite for AI-related stocks in the city. “We see ourselves like a SpaceX-style company,” Lai Tsai-Ta, co-founder and CEO of METiS TechBio, who obtained a PhD from the Massachusetts Institute of Technology in the US, said. “We use AI algorithms to design a large number of...
Azizul Kamal has spent a decade building his legal career in Singapore, but half of the time, he was hopping from one contract role to another in the industry. “Every company seems to only want to hire contractors, because we’re cheaper for balance books. It’s very hard to find a full-time role,” the 38-year-old Singaporean said. Azizul did not secure a third extension as a lawyer at his previous ...
Azizul Kamal has spent a decade building his legal career in Singapore, but half of the time, he was hopping from one contract role to another in the industry. “Every company seems to only want to hire contractors, because we’re cheaper for balance books. It’s very hard to find a full-time role,” the 38-year-old Singaporean said. Azizul did not secure a third extension as a lawyer at his previous firm, after it found a permanent replacement based in Kuala Lumpur, he said. With bills to pay, he...
After the Louisiana Purchase from France in 1803, which almost doubled the size of the United States’ territory, US president Thomas Jefferson commissioned the legendary Lewis and Clark expedition, which surveyed new routes from the Missouri river to the Pacific coast. It also carried out work in agriculture, ethnography (with indigenous peoples) and geography. Throughout the 19th and early 20th c...
After the Louisiana Purchase from France in 1803, which almost doubled the size of the United States’ territory, US president Thomas Jefferson commissioned the legendary Lewis and Clark expedition, which surveyed new routes from the Missouri river to the Pacific coast. It also carried out work in agriculture, ethnography (with indigenous peoples) and geography. Throughout the 19th and early 20th centuries, that was the kind of science the US government was willing to pay for – practical,...